MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijgc.2025.101631

Медицинская библиотека · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2025

Trends and comparisons of palliative care utilization for patients with metastatic gynecologic malignancy.

Lee Matthew W, Sriprasert Intira, Phung Peter G, Pino Christian, Woll Sabrina M, Vallejo Andrew, Furey Katelyn B, Muderspach Laila I, Roman Lynda D, Wright Jason D, Matsuo Koji

СтатьяСравнительное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To assess the use of non-curative interventions and palliative pain management for patients with advanced gynecologic malignancy in the United States.

METHODS

This retrospective cohort study queried the Commission-on-Cancer's National Cancer Database. The study population was 2,098,291 patients with stage IV malignancies from 2004 to 2020, including 5 gynecologic malignancies (uterine cervix, uterine corpus, tubo-ovary, vulva, and vagina) and 7 non-gynecologic malignancies (lung, pancreas, colorectum, breast, kidney, liver, and bladder), stratified by gender. Utilization rates and temporal trends of non-curative interventions (systemic therapy, surgery, radiotherapy) and palliative pain management in the first course of intervention were evaluated across the malignancy types.

RESULTS

In 19 gender-stratified malignancy groups, the median rate of non-curative interventions and palliative pain management use rate was 18.3%. All the gynecologic malignancies ranked below the median, including the 3 lowest groups (12.6%, 10.5%, and 7.8% for uterine corpus, vulva, and tubo-ovary, respectively). Non-curative interventions and palliative pain management use increased significantly in non-gynecologic malignancies, whereas utilization remained unchanged over several years for most gynecologic malignancies, including uterine cervix (19.8% to 20.1% for 2012-2020, p-trend = .744), uterine corpus (12.0% to 13.4% for 2013-2020, p-trend = .072), and tubo-ovary (8.3% to 9.2% for 2011-2020, p-trend = .311). Compared with non-gynecologic malignancies, patients with gynecologic malignancy were less likely to receive non-curative systemic therapy by 48% to 80% (all 5 types), non-curative surgery by 15% to 61% (all but vagina), non-curative radiotherapy by 37% to 95% (uterus, tubo-ovary, vulva), and palliative pain management by 18% to 45% (all 5 types) (all, adjusted-p < .05).

CONCLUSIONS

In this cohort study, the initial utilization of non-curative interventions and palliative pain management has been unchanged for patients with advanced gynecologic malignancy, and fewer patients receive palliative care than those with non-gynecologic malignancy, including palliative pain management. Possible under-utilization of palliative care services for patients with advanced gynecologic malignancy call for attention and further investigation.

Для цитирования: Lee Matthew W, Sriprasert Intira, Phung Peter G, Pino Christian, Woll Sabrina M, Vallejo Andrew, Furey Katelyn B, Muderspach Laila I, Roman Lynda D, Wright Jason D, Matsuo Koji. Trends and comparisons of palliative care utilization for patients with metastatic gynecologic malignancy.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2025. DOI: 10.1016/j.ijgc.2025.101631.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.